Elevai Labs

Update in progress

ELAB (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

PMGC Holdings Inc. is a Newport Beach, California-based company focused on aesthetics, therapeutics, and applied engineering. It operates in three segments: biosciences and corporate activities; IT packaging solutions; and precision engineering and machining. Its lead product, EL-22, is an engineered probiotic to help preserve muscle during obesity treatment with GLP-1 therapies. It also conducts medical R&D, investments, and packaging plus high-tolerance components. Formerly Elevai Labs, renamed December 2024; founded 2020.

Company score

Sentiment: 0.17; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.00; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.26; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.06; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.11; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive